Diabetespatienten sind durch eine chronische Kompromittierung des Immunsystems vulnerabler
für Infektionen und haben schwerere Krankheitsverläufe. Sie zählen deshalb gemäß der
ständigen Impfkommission (STIKO) zur Patientengruppe mit chronischen Erkrankungen
und sollten neben allen empfohlenen Standardimpfungen bedeutsame Indikationsimpfungen
erhalten, darunter die seit August 2024 empfohlene Vakzinierung gegen das respiratorische
Synzytialvirus (RSV).
Abstract
People with diabetes have an increased susceptibility to infections and tend to experience
more severe disease courses due to chronic immune dysfunction. The German Standing
Committee on Vaccination (STIKO) recommends that people with diabetes receive all
standard vaccinations and relevant indication-based vaccines in a timely manner. These
include immunizations against influenza, pneumococcal disease, COVID-19, RSV, herpes
zoster, hepatitis B, and tick-borne encephalitis (FSME). Vaccines can often be coadministered
for convenience and improved adherence. Since this year, new vaccines against influenza
and RSV are available. Age, immune status, comorbidities, and region-specific risks
should guide vaccination decisions. Ensuring adequate vaccination coverage in people
with diabetes is a key preventive strategy to reduce infection-related complications,
hospitalizations, and mortality.
Schlüsselwörter
Diabetes - Impfung - Indikationsimpfung - Auffrischimpfung - RSV - Influenza
Keywords
Diabetes - indication vaccination - booster vaccination - respiratory syncytial virus
- RSV - Influenza
